Novarad is set to unveil its innovative surgical augmented reality platform, VisAR, at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Toronto from April 11–15, 2026. This platform aims to enhance image-guided procedures by providing improved visualization and seamless integration into existing workflows. Attendees can experience live demonstrations of VisAR at Booth 1625, showcasing its capabilities in applications such as needle guidance, which highlights the platform’s potential to improve precision in clinical settings.

The significance of VisAR lies in its ability to streamline complex interventional procedures, addressing a critical need for technologies that are both intuitive and efficient. According to David Grandpre, VP of Product at Novarad, the focus is on delivering augmented reality solutions that enhance operational speed without compromising accuracy. This approach could potentially reduce procedural times and improve patient outcomes by minimizing the cognitive load on clinicians, allowing them to focus more on the procedure rather than on navigating complex technologies.

The introduction of VisAR could shift current paradigms in interventional radiology by promoting the adoption of augmented reality tools in clinical practice. As the demand for minimally invasive procedures continues to rise, integrating such technologies may accelerate the development timelines for new therapeutic approaches that rely on precision imaging. This could lead to a broader acceptance of augmented reality in various medical fields, ultimately enhancing the overall quality of care and expanding the therapeutic landscape for aging populations.

Source: globenewswire.com